{"id":22677,"date":"2025-10-20T11:03:45","date_gmt":"2025-10-20T11:03:45","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=22677"},"modified":"2025-10-20T11:03:45","modified_gmt":"2025-10-20T11:03:45","slug":"taiho-pharma-exercises-exclusive-license-for-casdatifan","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/taiho-pharma-exercises-exclusive-license-for-casdatifan\/","title":{"rendered":"\u5927\u9d6c\u85ac\u54c1\u3001Casdatifan\u306e\u72ec\u5360\u7684\u30e9\u30a4\u30bb\u30f3\u30b9\u3092\u884c\u4f7f"},"content":{"rendered":"<p>\u5927\u9d6c\u85ac\u54c1\u5de5\u696d\u682a\u5f0f\u4f1a\u793e\u3068 Arcus Biosciences, Inc.\u306f\u3001\u4f4e\u5206\u5b50\u306e HIF\uff08\u4f4e\u9178\u7d20\u8a98\u5c0e\u56e0\u5b50\uff09-2\u03b1\u963b\u5bb3\u5264\u3067\u3042\u308b casdatifan\uff08\u56fd\u969b\u975e \u72ec\u5360\u7684\u540d\u79f0\u3001\u958b\u767a\u30b3\u30fc\u30c9\uff1aAB521\uff09\u306b\u3064\u3044\u3066\u3001\u5927\u9d6c\u85ac\u54c1\u5de5\u696d\u304c\u65e5\u672c\u304a\u3088\u3073\u30a2\u30b8\u30a2\u306e\u4e00\u90e8\u306e\u5730\u57df\uff08\u4e2d\u56fd\u672c\u571f\u3092\u9664\u304f\uff09\u3067\u958b\u767a\u3057\u3001\u627f\u8a8d\u3055\u308c\u308c\u3070\u5546\u696d\u5316\u3059\u308b\u305f\u3081\u306e\u30aa\u30d7\u30b7\u30e7\u30f3\u6a29\u3092\u884c\u4f7f\u3057\u305f\u3068\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u672c\u30aa\u30d7\u30b7\u30e7\u30f3\u884c\u4f7f\u306f\u3001\u5927\u9d6c\u85ac\u54c1\u5de5\u696d\u3068Arcus\u793e\u304c2017\u5e74\u306b\u7de0\u7d50\u3057\u305f\u30aa\u30d7\u30b7\u30e7\u30f3\u5951\u7d04\u304a\u3088\u3073\u30e9\u30a4\u30bb\u30f3\u30b9\u5951\u7d04\u306b\u57fa\u3065\u304f\u3082\u306e\u3067\u3059\u3002\u5927\u9d6c\u85ac\u54c1\u306b\u3088\u308b\u30a2\u30eb\u30ab\u30b9\u793e\u306e\u30d7\u30ed\u30b0\u30e9\u30e0\u306b\u5bfe\u3059\u308b\u30aa\u30d7\u30b7\u30e7\u30f3\u884c\u4f7f\u306f\u3001\u4eca\u56de\u30675\u56de\u76ee\u3068\u306a\u308a\u307e\u3059\u3002<\/p>\n<p>\u5927\u9d6c\u85ac\u54c1\u5de5\u696d\u306f\u3001casdatifan\u306e\u72ec\u5360\u7684\u30e9\u30a4\u30bb\u30f3\u30b9\u3068\u5f15\u304d\u63db\u3048\u306b\u3001\u30aa\u30d7\u30b7\u30e7\u30f3\u6a29\u306e\u884c\u4f7f\u3068\u3001\u81e8\u5e8a\u3001\u898f\u5236\u3001\u5546\u696d\u5316\u306e\u30de\u30a4\u30eb\u30b9\u30c8\u30fc\u30f3\u9054\u6210\u306b\u5fdc\u3058\u305f\u8ffd\u52a0\u652f\u6255\u3044\u3092\u884c\u3044\u3001\u307e\u305f\u3001\u672c\u30d7\u30ed\u30b0\u30e9\u30e0\u306e\u88fd\u54c1\u304c\u627f\u8a8d\u3055\u308c\u305f\u5834\u5408\u306b\u306f\u3001\u5f53\u8a72\u88fd\u54c1\u306e\u7d14\u58f2\u4e0a\u9ad8\u306b\u5fdc\u3058\u305f\u30ed\u30a4\u30e4\u30eb\u30c6\u30a3\u3092\u652f\u6255\u3044\u307e\u3059\u3002<\/p>\n<p>\u30ab\u30b9\u30c0\u30c1\u30d5\u30a1\u30f3\u306f\u30a2\u30eb\u30ab\u30b9\u793e\u304c\u958b\u767a\u3057\u305f\u4f4e\u5206\u5b50\u5316\u5408\u7269\u3067\u3059\u3002\u73fe\u5728\u3001\u30a2\u30fc\u30ab\u30b9\u3067\u306f\u900f\u660e\u7d30\u80de\u814e\u7d30\u80de\u304c\u3093\u60a3\u8005\u3092\u5bfe\u8c61\u306b\u3001\u30ab\u30b9\u30c0\u30c1\u30d5\u30a1\u30f3\u3068VEGFR\u6a19\u7684\u30c1\u30ed\u30b7\u30f3\u30ad\u30ca\u30fc\u30bc\u963b\u5bb3\u5264\uff08TKI\uff09\u306e\u4f75\u7528\u7642\u6cd5\u3068VEGFR\u6a19\u7684TKI\u5358\u5264\u7642\u6cd5\u3092\u6bd4\u8f03\u3059\u308b\u56fd\u969b\u5171\u540c\u7b2c3\u76f8\u767b\u9332\u8a66\u9a13PEAK-1*\u3092\u5b9f\u65bd\u4e2d\u3067\u3059\u3002\u65e5\u672c\u30822026\u5e74\u524d\u534a\u304b\u3089\u672c\u8a66\u9a13\u306b\u53c2\u52a0\u3059\u308b\u4e88\u5b9a\u3067\u3059\u3002<\/p>\n<h4>\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a <a class=\"p-url\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/alpha-fusion-and-kobe-hospital-launch-at-211-drug-system\/\" rel=\"bookmark\">\u30a2\u30eb\u30d5\u30a1\u30d5\u30e5\u30fc\u30b8\u30e7\u30f3\u3068\u795e\u6238\u75c5\u9662\u304cAt-211\u30c9\u30e9\u30c3\u30b0\u30b7\u30b9\u30c6\u30e0\u3092\u767a\u58f2<\/a><\/h4>\n<p>\u3053\u306e\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u901a\u3058\u3066 <a href=\"https:\/\/www.taiho.co.jp\/\">\u5927\u9d6c<\/a> \u305d\u3057\u3066 <a href=\"https:\/\/arcusbio.com\/\">\u30a2\u30eb\u30ab\u30b9<\/a> \u306f\u3001\u9769\u65b0\u7684\u306a\u65b0\u85ac\u3068\u306a\u308a\u3046\u308b\u30ab\u30b9\u30c0\u30c1\u30d5\u30a1\u30f3\u3092\u3001\u60a3\u8005\u3055\u3093\u3084\u533b\u7642\u5f93\u4e8b\u8005\u306e\u65b9\u3005\u306b\u4e00\u523b\u3082\u65e9\u304f\u304a\u5c4a\u3051\u3059\u308b\u3053\u3068\u3092\u304a\u7d04\u675f\u3057\u307e\u3059\u3002<\/p>\n<p>\u30ab\u30b9\u30c0\u30c1\u30d5\u30a1\u30f3\u306fHIF-2\u03b1\u306e\u4f4e\u5206\u5b50\u963b\u5bb3\u5264\u3067\u3059\u3002HIF-2\u03b1\u306f\u4f4e\u9178\u7d20\u30ec\u30d9\u30eb\u306b\u53cd\u5fdc\u3057\u3066\u6570\u767e\u306e\u907a\u4f1d\u5b50\u3092\u30aa\u30f3\u306b\u3059\u308b\u30de\u30b9\u30bf\u30fc\u30b9\u30a4\u30c3\u30c1\u3067\u3001\u9178\u7d20\u30ec\u30d9\u30eb\u304c\u6b63\u5e38\u306b\u623b\u308b\u3068HIF-2\u03b1\u306f\u30aa\u30d5\u306b\u306a\u308a\u307e\u3059\u3002\u6700\u3082\u4e00\u822c\u7684\u306a\u814e\u81d3\u764c\uff08\u660e\u7d30\u80de\u814e\u7d30\u80de\u764c\uff09\u306e\u5927\u591a\u6570\u3067\u306f\u3001\u3053\u306e\u30b7\u30e3\u30c3\u30c8\u30aa\u30d5\u6a5f\u69cb\u304c\u6b20\u640d\u3057\u3066\u304a\u308a\u3001HIF-2\u03b1\u306f\u9178\u7d20\u306e\u5b58\u5728\u4e0b\u3067\u3082\u6d3b\u6027\u5316\u3055\u308c\u305f\u307e\u307e\u3067\u3042\u308b\u305f\u3081\u3001\u6b63\u5e38\u306a\u814e\u81d3\u7d30\u80de\u304c\u764c\u5316\u3057\u3066\u3057\u307e\u3046\u306e\u3067\u3059\u3002\u30ab\u30b9\u30c0\u30c1\u30d5\u30a1\u30f3\u306f\u3001HIF-2\u03b1\u7d4c\u8def\u3092\u3088\u308a\u6df1\u304f\u3001\u3088\u308a\u6301\u7d9a\u7684\u306b\u963b\u5bb3\u3059\u308b\u3088\u3046\u306b\u8a2d\u8a08\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p><strong>\u30bd\u30fc\u30b9 <a href=\"https:\/\/www.businesswire.com\/news\/home\/20251019482380\/en\/Taiho-Pharmaceutical-Exercises-Option-for-an-Exclusive-License-to-Casdatifan-in-Japan-and-Certain-Territories-in-Asia\">\u30d3\u30b8\u30cd\u30b9\u30ef\u30a4\u30e4\u30fc<\/a><\/strong><\/p>","protected":false},"excerpt":{"rendered":"<p>Taiho Pharmaceutical Co., Ltd. and Arcus Biosciences, Inc. announced that Taiho exercised its option to develop and, if approved, commercialize casdatifan (International Nonproprietary Name; development code: AB521), an investigational small molecule HIF (Hypoxia Inducible Factor)-2\u03b1 inhibitor, in Japan and certain other territories in Asia (excluding mainland China). This option exercise is based on a 2017 option and license agreement between Taiho and Arcus. This is the fifth option exercise by Taiho to an Arcus program. In exchange for the exclusive license to casdatifan, Taiho will make an option exercise payment, as well as additional payments upon achievement of clinical, regulatory and commercialization milestones, and, if any products from the program [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":22704,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[208,89,211,237,182,206],"tags":[8655,3503,8656,424,7303],"ppma_author":[205],"class_list":{"0":"post-22677","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-apac","8":"category-health-tech","9":"category-japan","10":"category-news","11":"category-pharma","12":"category-regional","13":"tag-arcus-biosciences","14":"tag-biotechnology","15":"tag-casdatifan","16":"tag-pharma","17":"tag-taiho-pharmaceutical"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Taiho Pharma Secures Casdatifan License in Asia<\/title>\n<meta name=\"description\" content=\"Taiho Pharmaceutical exercises its option to commercialize casdatifan in Japan and select Asian territories with Arcus Biosciences.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/taiho-pharma-exercises-exclusive-license-for-casdatifan\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Taiho Pharma Secures Casdatifan License in Asia\" \/>\n<meta property=\"og:description\" content=\"Taiho Pharmaceutical exercises its option to commercialize casdatifan in Japan and select Asian territories with Arcus Biosciences.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/taiho-pharma-exercises-exclusive-license-for-casdatifan\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-20T11:03:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Taiho-Pharmaceutical-Exercises-Option-for-an-Exclusive-License-to-Casdatifan-in-Japan-and-Certain-Territories-in-Asia.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NewsDesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"NewsDesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u5927\u9d6c\u85ac\u54c1\u5de5\u696d\u304c\u30a2\u30b8\u30a2\u3067Casdatifan\u306e\u30e9\u30a4\u30bb\u30f3\u30b9\u3092\u53d6\u5f97","description":"\u5927\u9d6c\u85ac\u54c1\u5de5\u696d\u3001Arcus Biosciences\u793e\u3068\u30ab\u30b9\u30c0\u30c1\u30d5\u30a1\u30f3\u306e\u65e5\u672c\u304a\u3088\u3073\u7279\u5b9a\u30a2\u30b8\u30a2\u5730\u57df\u306b\u304a\u3051\u308b\u5546\u696d\u5316\u30aa\u30d7\u30b7\u30e7\u30f3\u3092\u884c\u4f7f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/taiho-pharma-exercises-exclusive-license-for-casdatifan\/","og_locale":"ja_JP","og_type":"article","og_title":"Taiho Pharma Secures Casdatifan License in Asia","og_description":"Taiho Pharmaceutical exercises its option to commercialize casdatifan in Japan and select Asian territories with Arcus Biosciences.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/taiho-pharma-exercises-exclusive-license-for-casdatifan\/","og_site_name":"itbusinesstoday","article_published_time":"2025-10-20T11:03:45+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Taiho-Pharmaceutical-Exercises-Option-for-an-Exclusive-License-to-Casdatifan-in-Japan-and-Certain-Territories-in-Asia.webp","type":"image\/webp"}],"author":"NewsDesk","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"NewsDesk","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/taiho-pharma-exercises-exclusive-license-for-casdatifan\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/taiho-pharma-exercises-exclusive-license-for-casdatifan\/"},"author":{"name":"NewsDesk","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/d58d81f55e8acd257ab63d49fb4ea812"},"headline":"Taiho Pharma Exercises Exclusive License for Casdatifan","datePublished":"2025-10-20T11:03:45+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/taiho-pharma-exercises-exclusive-license-for-casdatifan\/"},"wordCount":318,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/taiho-pharma-exercises-exclusive-license-for-casdatifan\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Taiho-Pharmaceutical-Exercises-Option-for-an-Exclusive-License-to-Casdatifan-in-Japan-and-Certain-Territories-in-Asia.webp","keywords":["Arcus Biosciences","Biotechnology","Casdatifan","Pharma","Taiho Pharmaceutical"],"articleSection":["APAC","Health Tech","Japan","News","Pharma","Regional"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/taiho-pharma-exercises-exclusive-license-for-casdatifan\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/taiho-pharma-exercises-exclusive-license-for-casdatifan\/","name":"\u5927\u9d6c\u85ac\u54c1\u5de5\u696d\u304c\u30a2\u30b8\u30a2\u3067Casdatifan\u306e\u30e9\u30a4\u30bb\u30f3\u30b9\u3092\u53d6\u5f97","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/taiho-pharma-exercises-exclusive-license-for-casdatifan\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/taiho-pharma-exercises-exclusive-license-for-casdatifan\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Taiho-Pharmaceutical-Exercises-Option-for-an-Exclusive-License-to-Casdatifan-in-Japan-and-Certain-Territories-in-Asia.webp","datePublished":"2025-10-20T11:03:45+00:00","description":"\u5927\u9d6c\u85ac\u54c1\u5de5\u696d\u3001Arcus Biosciences\u793e\u3068\u30ab\u30b9\u30c0\u30c1\u30d5\u30a1\u30f3\u306e\u65e5\u672c\u304a\u3088\u3073\u7279\u5b9a\u30a2\u30b8\u30a2\u5730\u57df\u306b\u304a\u3051\u308b\u5546\u696d\u5316\u30aa\u30d7\u30b7\u30e7\u30f3\u3092\u884c\u4f7f\u3002.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/taiho-pharma-exercises-exclusive-license-for-casdatifan\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/pharma\/taiho-pharma-exercises-exclusive-license-for-casdatifan\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/taiho-pharma-exercises-exclusive-license-for-casdatifan\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Taiho-Pharmaceutical-Exercises-Option-for-an-Exclusive-License-to-Casdatifan-in-Japan-and-Certain-Territories-in-Asia.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/10\/Taiho-Pharmaceutical-Exercises-Option-for-an-Exclusive-License-to-Casdatifan-in-Japan-and-Certain-Territories-in-Asia.webp","width":1200,"height":800,"caption":"Taiho Pharmaceutical"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/taiho-pharma-exercises-exclusive-license-for-casdatifan\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Taiho Pharma Exercises Exclusive License for Casdatifan"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/d58d81f55e8acd257ab63d49fb4ea812","name":"\u30cb\u30e5\u30fc\u30b9\u30c7\u30b9\u30af","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png74f313ad3d6fa27a1eee85c30be63d03","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","caption":"NewsDesk"},"sameAs":["https:\/\/itbusinesstoday.com"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/newsdesk\/"}]}},"authors":[{"term_id":205,"user_id":4,"is_guest":0,"slug":"newsdesk","display_name":"NewsDesk","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png"},"0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/22677","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=22677"}],"version-history":[{"count":1,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/22677\/revisions"}],"predecessor-version":[{"id":22678,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/22677\/revisions\/22678"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/22704"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=22677"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=22677"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=22677"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=22677"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}